http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
우울장애 환자에서 양극성 기분성향에 따른 불안민감성과 공황증상 비교
임종길(Jong Gil Lim),강태욱(Tae Uk Kang),문은수(Eunsoo Moon),박제민(Je Min Park),이병대(Byung Dae Lee),이영민(Young Min Lee),정희정(Hee Jeong Jeong),최윤미(Yoonmi Choi),박영민(Young Min Park) 대한생물치료정신의학회 2017 생물치료정신의학 Vol.23 No.3
Objectives:A few studies have shown that some anxiety disorders, especially panic disorder, are more related with bipolar than with unipolar depressive disorder. However, there is lack of evidence on the different patterns of anxiety sensitivity and panic-related symptoms, depending on bipolarity in patients with depression. This study was aimed at comparing anxiety sensitivity and panic-related symptoms between patients with depression with and without bipolarity. Methods:We recruited 158 patients who experiencing depressive disorders. Bipolarity was evaluated with the Mood Disorder Questionnaire(MDQ). Panic-related symptoms and anxiety sensitivity were measured with the Anxiety Sensitivity Index-Revised(ASI-R), Acute Panic Inventory(API) and Korea Albany Panic and Phobia Questionnaire(K-APPQ). Anxiety sensitivity and panic-related symptoms were compared between patients with depression with positive and negative screen in the MDQ using independent t-test and analysis of covariance(ANCOVA). Results:Patients with depression who had a positive screen on the MDQ had higher ASI-R total and subscales scores(total score, p=0.012; fear of publicly observable anxiety reactions, p=0.002; fear of cognitive dyscontrol, p=0.009), API score(p=0.005), rate of API score with more than 20 points(p=0.021) than those with negative results on the MDQ. After adjust for age and Beck Depression Inventory(BDI) score, the differences between the two groups remained significant(ASI-R total score, p=0.012 ; ASI-R fear of publicly observable anxiety reactions, p=0.008 ; ASI-R fear of cognitive dyscontrol, p=0.012; API score, p=0.017). Additionally, a significant difference in the ASI-R subscale, fear of cardiovascular symptoms appeared between the two groups after adjusting for age and BDI score(p=0.042). Conclusion:The results suggested that the presence of bipolarity in patients with depression may be related to the frequency of panic symptoms and high anxiety sensitivity. The presence of bipolarity may need to be considered in treating comorbid panic disorder in patients with depression.
LiCl 용융염에서 전해환원법을 통한 La0.5Nd0.5Ni5 합금 제조
임종길 ( Jong Gil Lim ),정상문 ( Sang Mun Jeong ) 한국화학공학회 2015 Korean Chemical Engineering Research(HWAHAK KONGHA Vol.53 No.2
The electrochemical behavior of Nd2O3-La2O3-NiO mixed oxide including rare earth resources has been studied to synthesize La0.5Nd0.5Ni5 alloy in a LiCl molten salt. The Nd2O3-La2O3-NiO mixed oxide was converted to NiNd2O4 (spinel) and LaNiO3 (perovskite) structures at a sintering temperature of 1100 oC. The spinel and perovskite structures led a speed-up in the electrolytic reduction of the mixed oxide. Various reaction intermediates such as Ni, NiLa2O4 were observed during the electrochemical reduction by XRD analysis. A possible reaction route to La0.5Nd0.5Ni5 in the LiCl molten salt was proposed based on the analysis result.
팔리페리돈 장기 지속형 주사제 사용 후 정신과적 증상 및순응도 변화
박홍준(Hong Jun Park),김신겸(Shin Kyum Kim),변원탄(Won Tan Byun),정봉주(Bong Ju Jung),박영민(Young Min Park),서재원(Jae Won Seo),김세훈(Se Hoon Kim),임종길(Jong Gil Lim) 대한사회정신의학회 2019 사회정신의학 Vol.24 No.1
연구목적 : 조현병 환자에서 저하된 약물 순응도는 증상 재발의 주요한 원인 중 하나이다. 팔리페리돈 장기 지속형 주사제를 사용한 이후 환자의 정신과적 증상 및 약물 순응도의 변화를 측정하였다. 방 법 : 팔리페리돈 장기 지속형 주사제를 시작한 64명의 환자들을 대상으로, 한국형 양성 및 음성 증상 척도(Positive And Negative Syndrome Scale, 이하 PANSS) 및 약물 태도 척도(Drug Attitude Inventory-10, 이하 DAI)를 사용하여, 시작 전과 6개월 후의 정신과적 임상 증상과 약물 순응도 및 경구용 항정신병 약물 용량을 측정하였다. 또한 팔리페리돈 장기 지속형 주사제 사용 후 나타난 치료 효과와 임상적 요인의 관련성을 분석하였다. 결 과 : 팔리페리돈 장기 지속형 주사제 사용 후 정신 증상 및 약물 순응도가 개선된 것으로 나타났다. 로지스틱 회귀 분석 결과, 초기 경구용 항정신병 약물 용량이 낮을 수록, 6개월 간 경구용 항정신병 약물 감소량이 높을 수록 정신 증상의 호전과 연관성을 보였다. 6 개월 후 낮은 PANSS-P 점수는 약물 순응도의 호전과 연관성을 보였다. 결 론 : 팔리페리돈 장기 지속형 주사제 사용은 경구용 항정신병 약물을 감량하면서도 정신 증상의 악화를 최소화하며 약물 순응도를 개선시키는 결과를 나타내었다. Objectives : Poor drug adherence is a major cause of symptom relapse in the overall course of schizophrenia. We investigated the change of psychiatric symptoms and drug adherence following paliperidone palmitate long acting injection (PLAI) in patients with schizophrenia. Methods : Psychiatric symptoms and drug adherence were evaluated in 64 patients with schizophrenia at baseline and after 6-month use of PLAI. Korean version of Positive And Negative Syndrome Scale (PANSS) was used to evaluate the change of symptoms and Drug Attitude Inventory-10 (DAI) to estimate their drug adherence. We assessed concurrent dose of oral antipsychotics over time and associated treatment effectiveness with clinical variables. Results : Psychiatric symptoms and drug adherence were improved after use of PLAI. Logistic regression analysis showed treatment effectiveness of psychiatric symptoms was associated with lower dose of initial oral antipsychotics and higher decrement of oral antipsychotics dose. And the improvement of drug adherence was associated with lower score of end-point PANSS-P. Conclusion : PLAI is expected to be a promising strategy to reduce the dose of oral antipsychotics without worsening of psychiatric symptoms and drug adherence in schizophrenic patients.